HysensBio
- Biotech or pharma, therapeutic R&D
HysensBio is a company developing novel peptide dental therapeutics for dentin hypersensitivity, caries and periodontal diseases. We are also expanding our peptide technology to dermal therapeutics.
June 16-19, 2025
Boston Convention & Exhibition Center
HysensBio is a company developing novel peptide dental therapeutics for dentin hypersensitivity, caries and periodontal diseases. We are also expanding our peptide technology to dermal therapeutics.